The Indiana Health Industry Forum is the Biotechnology Industry Organization's (BIO) state affiliate member in Indiana. Members of IHIF are entitled to participate in service discounts offered through the BIO Discount Program.
BioSpace is globally recognized as the leading provider of web-based resources and information to the life science industry.
Indiana BioMedical Entrepreneur's Network (IBEN)
The Indiana Biomedical Entrepreneur Network (IBEN) strives to enable entrepreneurship in life sciences and medicine throughout Indiana. This is achieved through social networking, education and events featuring experienced entrepreneurs. IBEN is open to all who play a role or have an interest in biomedical entrepreneurship, from academics to product.
IU Kelley School of Business Life Sciences Collaboration Conference Series
The Indiana Life Sciences Collaboration is very proud to offer a four-conference series dealing with the most critical trends and issues facing companies that provide value to the life sciences value chain. Sign up now for any one conference for $40 per person or buy the whole series for $150. Bring your colleagues and best customers and spend some quality time networking with a fine collaboration of life sciences leaders and innovators. All our conferences begin at 8 on a Friday morning with continental breakfast and end with a lunch program. They are designed for maximal impact and to get you back to your office by Friday afternoon. Enrollment will be limited so please make sure you register in advance. Information on online and mail-in registration is available on the registration link above.
Life Science Lunch Series
Third Tuesday of every month 11:30 am - 1:00 pm
Barnes & Thornburg
5th Floor Conference Center
11 South Meridian Street
Indiana Health Industry Forum and Barnes & Thornburg LLP offer a free monthly seminar series on critical issues in life sciences. Each month, at lunch, a single expert or a panel will be make a brief presentation and answer questions concerning the challenges and opportunities in the life sciences industry. Held in Indianapolis and broadcast via videoconference to a number of locations across the state, each site will have a chance to ask questions.
Click the link to register for this month's Life Science Luncheon or call 317-231-7356 for more information. There is no cost to attend. Please see the calendar for this month's topic.
National Cancer Institute - SBIR & STTR Programs
The goal of the NCI is to eliminate the suffering and death due to cancer. The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs are NCI's engine of innovation for developing and commercializing novel technologies and products to prevent, diagnose, and treat cancer.
The SBIR & STTR Programs are one of the largest sources of early-stage technology financing in the United States. We welcome entrepreneurs and small business leaders to this website to explore grant and contract funding opportunities and a new spirit of collaboration with the NCI.
Academic and Independent Incubators
Economic Analysis of the Technological Infrastructure Needs of the US Biopharmaceutical Industry
Infrastructure Needs for the Biotech Industry, a November 2007 National Institutes of Technology report.
As biotechnology advances and a major biopharmaceutical industry evolves in the US, these firms and the industry at large will generate unique infrastructure demands on Federal, state and local governments. New research sponsored by the National Institute of Standards and Technology takes a closer look at the future needs and the present state of the biopharmaceutical industry's technological infrastructure. Technology infrastructure is a broad concept that includes equipment, tools, data, and methods needed to develop new technologies and products. The new research indicates that the industry now spends a whopping $1.2 billion each year on its technology infrastructure. Within this total, $884 million supports drug-related R&D and $335 million supports commercial manufacturing and other activities. To their credit, the researchers did not simply seek to tally up these costs. They also sought to estimate the benefits of major efficiency gains in this technology infrastructure. While the projections differ depending on specific individual circumstances, the researchers estimate potential savings in the range of 10-40% thanks to major improvements in key areas such as gene expression analysis, biomonitors, and bioinformatics. -Source "The National Dialogue on Entrepreneurship" is an initiative of the Public Forum Institute made possible by a grant from the Kauffman Foundation of Kansas City.
Midwestern Biotech Associations
Venture Capital Resources
If you would like to link to our site or have us add a link, Please send an e-mail to email@example.com